Saturday, August 29, 2020 11:59:55 AM
This will be huge. I laugh at the flipping going on by a few that just want to keep slowing down our Momo. Hopefully, the flippers will start holding for at least a penny gain before they flip instead of this .003-.004 range. Every time we blow away a huge ask wall, it goes up a little more then the flippers step in and sell into the bid to slow the Momo. Maybe it's not even flipping traders that are responsible, maybe just more MM games to keep control. One thing for sure, once the hearing has a decision handed down, this will start moving up in a big way. Nickel and dime increases in the price for days after and those that continue to flip for peanut gains here are crazy. What I do know, is the deep pockets that will be controlling the price here in the long term are still in loading mode and other funds and such can't even buy yet.....just wait until the price is over a nickel. It's going to get crazy up in here. Next week alone on speculation should put us easily over a nickel and probably closer to .09-.10 cents, IMO.
Glad to be here with you brother for another epic run!
PokerStar
Glad to be here with you brother for another epic run!
PokerStar
Recent BRTX News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2026 09:07:05 PM
- Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) • PR Newswire (Canada) • 05/27/2026 11:45:00 AM
- Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) • PR Newswire (US) • 05/27/2026 11:45:00 AM
- BioRestorative Completes Phase 2 Dosing of BRTX-100, Advancing Lead Regenerative Spine Program Toward 2027 Topline Data • GlobeNewswire Inc. • 05/26/2026 03:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 07:30:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:31:37 PM
- BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals • GlobeNewswire Inc. • 05/13/2026 03:00:00 PM
- BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 05/07/2026 04:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 08:17:58 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/30/2026 08:10:19 PM
- BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform • GlobeNewswire Inc. • 04/30/2026 02:36:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/27/2026 08:05:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2026 09:12:57 PM
- BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform • GlobeNewswire Inc. • 04/21/2026 12:00:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/20/2026 09:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/13/2026 09:22:23 PM
- BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform • GlobeNewswire Inc. • 04/07/2026 12:15:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/03/2026 06:46:20 PM
- BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 03/30/2026 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 08:20:29 PM
- BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 03/19/2026 12:00:00 PM
- BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026 • GlobeNewswire Inc. • 03/05/2026 01:00:00 PM
- BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy • GlobeNewswire Inc. • 03/04/2026 01:00:00 PM
- BioRestorative secures Australian patent protection for ThermoStem® obesity therapy platform • IH Market News • 02/24/2026 03:14:07 PM
